Consolidation in Animal Health: A Much-needed Growing Pain

Sep 15, 2016

During the two decades ending in 2015, the top ten human pharmaceutical companies – Pfizer, Novartis, Sanofi, Roche, Merck & Co, Johnson & Johnson, AstraZeneca, GSK, Teva and Gilead – were involved in over forty merger and acquisition (M&A) activities. Dr Sam Al-Murrani of Babylon BioConsulting LLC presents an analysis of the results of this process. The main drivers for these consolidation events were related to increasing regulatory pressures, falling research and development (R&D) productivity and the expiry of many patents that covered some of the high-earner pharmaceuticals ...

Read More

A GLIMPSE of How Agribusiness Can Feed the World

Sep 15, 2016

An acronym that veterinarians can use to summarise the factors holding back farming Aidan Connolly, Chief Innovation Officer & Vice President, Corporate Accounts at Alltech, wonders in this article if farming and farmers are ready to feed the world. Not just the world today, but the world of 2050 or 2100. GLIMPSE is designed to help those involved in farming, food and agribusiness to understand the seven words that summarise the challenges that, if overcome, will allow us to meet this demand and help secure food for us all. ...

Read More

Antimicrobial Stewardship in the UK Pig Industry

Sep 15, 2016

A Changing Landscape Lucy Coyne, MRCVS, AHDB Pork Veterinary Manager, submits a paper about the UK pig industry, which is acting to put itself in a more informed position on its antimicrobial use in light of global concern over antimicrobial usage and resistance. The recently published O’Neill report highlighted the issues around antimicrobial resistance in both humans and livestock, and the UK pig industry recognises its responsibility to measure and control its use of antimicrobials. ...

Read More